Alvogen Group

Alvogen is a privately-owned specialty pharmaceutical company based in Kópavogur, Iceland, with additional offices in the United States, South Korea, and Romania. Established in 2010, Alvogen focuses on the development, manufacturing, and marketing of generic pharmaceuticals, biosimilar products, and over-the-counter (OTC) medicines. The company's product portfolio includes a wide range of therapeutic solutions for oncology, cardiology, respiratory medicine, neurology, and gastroenterology, aimed at providing affordable medications to improve patient health. Alvogen also engages in contract manufacturing and contract research, further expanding its capabilities in the pharmaceutical market while striving to reduce healthcare costs globally.

Thor Kristjansson

Executive Vice President of M&A

Chris Young

Executive Vice President, Global Operations

Tunie Zaku

US CFO

Past deals in Romania

Labormed

Acquisition in 2012
LaborMed's initial focus was on building its portfolio of cardiovascular and central nervous systems treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.